Suven Pharmaceuticals
Manufacturing · India · 51-200 Employees
View Company Info for Free
Overview
Headquarters
A-wing Galaxy Towers 202 Knowledge City ...Phone Number
+91 4023549414Website
www.suvenpharm.comRevenue
$17.2 MillionIndustry
About Suven Pharmaceuticals
Suven Pharmaceuticals Org Chart
Is Suven Pharmaceuticals your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Suven Pharmaceuticals, which may be a good buyer, showed buying intent in Masked Content Topic
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Website visits: Recent activity has been detected on your website
Check out if Suven Pharmaceuticals is spiking on competitors!
Funding: Get notified immidiatlly once Suven Pharmaceuticals has new funding data
Earning: See what the market has to say on Suven Pharmaceuticals recently announced quarterly report
Check if Suven Pharmaceuticals has recently received funding, and reach out quickly before it becomes old news!
Congratulate Masked Content for being promoted to Masked Content at Suven Pharmaceuticals
Click to see if Suven Pharmaceuticals had a recent Job posting/layoffs
Product Launch: Get notified when Suven Pharmaceuticals launches new products
Recommended Actions
Introduce yourself to Masked Content, who has shown a strong intent to purchase lately
Find 3 more new buyers
Company Profile Activity
Activity Insights
Suven Pharmaceuticals is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
Suven Pharmaceuticals is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Suven Pharmaceuticals.
Suven Pharmaceuticals Tech Stack
A closer look at the technologies used by Suven Pharmaceuticals
Most Recent Scoops
Suven Pharmaceuticals News & Media
Suven Pharmaceuticals acquires controlling stake in NJ Bio for USD 64.4 million
Suven Pharmaceuticals Limited, a leading CDMO specialising in innovative drug modalities, has acquired a 56 per cent controlling stake in NJ Bio Inc., an ADC-focused CRDMO based in Princeton, for USD 64.4 million.Suven Pharmaceuticals acquires controlling stake in US-based NJ Bio - CNBC TV18
The transaction positions Suven as a key player in the ADC outsourcing market, which is currently valued at $2.7 billion (approx ₹22,815 crore) and projected to grow at over 25% annually.Cohance, Suven Merger Approved by NSE and BSE | Hyderabad News - Times of India
Read about the approval of the Cohance and Suven merger by the National Stock Exchange (NSE) and Bombay Stock Exchange (BSE). The combined entity will be a leading player in contract development and manufacturing in the pharmaceutical industry.Suven Pharmaceuticals to gain controlling stake in Sapala Organics
Suven intends to purchase the remaining shares, ultimately owning 100% of Sapala Organics’ share capital.
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Suven Pharmaceuticals
Suven Pharma specializes in providing comprehensive pharmaceutical services, including formulation development, process research, custom synthesis, and clinical supplies manufacturing. The company caters to global pharmaceutical clients, focusing on the commercialization of new chemical entities. With a commitment to quality and customer satisfacti... Read More